「Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib」の関連論文
-
Assessment of Automatic Software for Detecting Radiographic Joint Space Narrowing Progression in Rheumatoid Arthritis [an abstract of entire text]
-
PTEN is a predictive biomarker of trastuzumab resistance and prognostic factor in HER2-overexpressing gastroesophageal adenocarcinoma
-
Clinicopathological and molecular features of responders to nivolumab for patients with advanced gastric cancer
-
The landscape of genetic aberrations in myxofibrosarcoma
-
An autopsy case of primary gliosarcoma with multiple extracranial metastases: pathology after administration of bevacizumab and genetic profile
-
Distinctive roles of syntaxin binding protein 4 and its action target, TP63, in lung squamous cell carcinoma: a theranostic study for the precision medicine
-
Colorectal cancer-derived CAT1-positive extracellular vesicles alter nitric oxide metabolism in endothelial cells and promote angiogenesis
-
Potential Benefits of Bevacizumab Combined With Platinum-Based Chemotherapy in Advanced Non–Small-Cell Lung Cancer Patients With EGFR Mutation
-
Optimized radiotherapy treatment strategy for early glottic carcinoma
-
Therapeutic Potential of Valproic Acid for Postviral Olfactory Dysfunction: A Single-Arm Pilot Study.
-
Differential effects of combination therapy on the components of the risk stratification table in patients with idiopathic or heritable pulmonary arterial hypertension in a Japanese population
-
Design of Novel Targeted Co-delivery System for Combined Chemotherapy and Gene Therapy of Hepatocellular Carcinoma [an abstract of entire text]
-
Comprehensive Investigations of Multiple Factors That Are Related to Refractory Outcome in Urosepsis Patients
-
Comprehensive genomics in androgen receptor-dependent castration-resistant prostate cancer identifies an adaptation pathway mediated by opioid receptor kappa 1
-
TSC22D4/THG-1 suppresses cellular senescence in esophageal squamous cell carcinoma
-
Factors causing a relapse of major depressive disorders following successful electroconvulsive therapy : A retrospective cohort study
-
The Combination of Prognostic Nutritional Indicator and Serum Carcinoembryonic Antigen is Useful in Predicting Postoperative Recurrence in Stage II Colorectal Cancer
-
T-cell response to phytohemagglutinin in the interferon-γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non-small cell lung cancer
-
Dysbiosis of the salivary microbiota in pediatric-onset primary sclerosing cholangitis and its potential as a biomarker
-
Gut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion
-
Urinary MicroRNA-Based Diagnostic Model for Central Nervous System Tumors Using Nanowire Scaffolds
-
Relationship between stromal regulatory T cells and the response to neoadjuvant chemotherapy for locally advanced rectal cancer
-
Clinical Implications of Naples Prognostic Score in Patients with Resected Pancreatic Cancer
-
Association of CD4-positive cell infiltration with response to vedolizumab in patients with ulcerative colitis
-
Potential roles of gastroesophageal reflux in patients with superficial esophageal squamous cell carcinoma without major causative risk factors
-
Clinical characteristics and outcomes of the right congenital diaphragmatic hernia compared to the left: a 10-year single-center experience
-
Amino acid catabolite markers for early prognostication of pneumonia in patients with COVID-19
-
Real-life progression of the use of a genetic panel in to diagnose neonatal cholestasis
-
Genome-wide association studies on hepatocellular carcinoma after eradication of hepatitis C virus in Japanese and on chronic hepatitis B in Thai
-
MYC Upregulation Is a Useful Biomarker for Preoperative Neoadjuvant Chemotherapy Combined With Anti-EGFR in Liver Metastasis from Colorectal Cancer
-
Local radiotherapy for pleural dissemination of thymic tumors after initial treatment
-
Outcomes of palliative surgery for bone metastasis of metastatic renal cell carcinoma in the era of targeted therapy
-
Efficacy and safety of S-1 following gemcitabine with cisplatin for advanced biliary tract cancer
-
Optimal use of anthracycline-free perioperative chemotherapy in HER2-positive breast cancer patients (本文)
-
Polo-like kinase 4 and stromal antigen 3 are not associated with recurrent pregnancy loss caused by embryonic aneuploidy
-
A case of Erdheim–Chester disease with the BRAF V600E mutation diagnosed via endoscopic sinus surgery
-
Survival Analyses Based on Tumor Microenvironment Profile in Endometrial Carcinoma
-
EYS is a major gene involved in retinitis pigmentosa in Japan: Genetic landscapes revealed by stepwise genetic screening.
-
IL-18 binding protein can be a prognostic biomarker for idiopathic pulmonary fibrosis
-
IL-18 binding protein can be a prognostic biomarker for idiopathic pulmonary fibrosis
-
The impact of chronic Epstein–Barr virus infection on the liver graft of pediatric liver transplant recipients: A retrospective observational study
-
MDM4 as a prognostic factor for patients with gastric cancer with low expression of p53:immunohistochemical study of p53, MDM2, and MDM4
-
Repurposing bromocriptine for Aβ metabolism in Alzheimer’s disease (REBRAnD) study: randomised placebo-controlled double-blind comparative trial and open-label extension trial to investigate the safety and efficacy of bromocriptine in Alzheimer’s disease with presenilin 1 (PSEN1) mutations
-
Clinical and genetic investigation of 136 Japanese patients with congenital hypothyroidism
-
Significance of Wnt/β-Catenin Signal Activation for Resistance to Neoadjuvant Chemoradiotherapy in Rectal Cancer
-
Autoantibodies against the plakin family proteins as a novel marker for chronic graft-versus-host disease of the lung
-
Phase III clinical trial of autologous CD34 + cell transplantation to accelerate fracture nonunion repair
-
Relative hypercoagulation induced by suppressed fibrinolysis after tisagenlecleucel infusion in malignant lymphoma
-
Reverse Genetic Studies on Mitochondrial tRNA-related Disorders
-
外科的に切除された膵癌におけるST2発現の臨床病理学的及び予後との関連性の検討